Electronic Clinical Outcome Assessment Solutions Market Is Segmented On The Basis Of Delivery Mode, End Use, And Region 2014-2025

Global Electronic Clinical Outcome Assessment (eCOA) Solutions Market is expected to reach USD 2.16 billion by 2025, according to a new report by Grand View Research, Inc. The complexity in healthcare information management is anticipated to fuel the demand for eCOA solutions in coming years. These solutions deliver accurate and timely health information and reduce burden of patients enrolled in clinical trials. 

eCOA measures overall mental state, patient symptoms, and the progression of a disease. Electronic diaries and electronic Patient Reported Outcomes (ePRO) are a part of eCOA platforms. Electronic diaries help document patient response. These are used as support systems for ePRO. In all the applications of clinical outcome assessment systems, the compliance rates are more than 90%, which helps accelerate research procedures. 

In addition, assessment systems help detect probable adverse conditions in advance for patients, which is crucial for taking preventive measures to avoid adverse effects in future. The ePRO platforms transfer real-time data from the patients to healthcare professionals for accurate decision-making and better evaluation of a patient’s health. Thus, the adoption of these platforms is expected to grow in near future. 

Growing adoption of software solutions during research studies, high R&D expenditure by pharmaceutical companies, favorable government grants to support clinical trials, and widening base of potential customers are some of the key contributing factors for market growth.

Access Full Research Report on Global Electronic Clinical Outcome Assessment (eCOA) Solutions Market: http://www.grandviewresearch.com/industry-analysis/electronic-clinical-outcome-assessment-ecoa-solutions-market

Further Key Findings From the Study Suggest: 

• Rising adoption of technologically advanced wearable and handheld medical devices helps capture clinical outcomes electronically, further making the medical information assessment easier
• The core advantage of web-based services is ability to access information from remote locations using only one computer or monitoring device in healthcare settings
• Cloud-based solutions are anticipated to grow at an exponential rate owing to integrated features that include flexibility, high accessibility, negligible handling costs, and easy data backup
• Contract research organizations dominated the market as major pharmaceutical companies are focused on reducing expenditure on clinical trials
• North America held the largest market share owing to the local presence of well-established market players coupled with large number of ongoing research in this region
• Asia Pacific market is expected to show fastest growth over the forecast period owing to the availability of a large number of contract research firms offering eCOA platforms to large pharmaceuticals
• The companies are making significant investments to implement eClinical solutions in order to manage medical information, owing to the benefits it offers 

View More Related Reports from same category by Grand View Research: http://www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the Global Electronic Clinical Outcome Assessment (eCOA) Solutions Market on the basis of the delivery mode, end use, and region: 

eCOA Solutions Delivery Mode Outlook (Revenue, USD Million, 2014 - 2025)

• Web hosted
• Licensed enterprise
• Cloud based

eCOA Solutions End-use Outlook (Revenue, USD Million, 2014 - 2025)

• Hospitals
• CROs
• Academic Institutes
• Pharma & Biotech Organizations
• Medical Device Manufacturers

eCOA Solutions Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• Japan
• China
• India
• Latin America
• Mexico
• Brazil
• MEA
• South Africa
• Saudi Arabia 

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-electronic-clinical-outcome-assessment-ecoa-solutions-market    

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Eubiotics Market Is Expected To Grow At A CAGR Of 8.2% From 2017 To 2025

Global Eubiotics Market is expected to reach USD 9.4 billion by 2025, according to a new report by Grand View Research, Inc. Growing meat consumption coupled with rising awareness regarding meat quality is expected to drive global eubiotics market growth.

Eubiotics influence the gut microflora and confer health benefits on the host. They maintain a correct balance of the microbial activity in the gastrointestinal tract of animals. This results in benefits such as enhanced nutrient absorption, better immunity and increase in overall performance. Such advantages are expected to drive the market growth over the forecast period.

Probiotics emerged as the largest product segment in 2016 and was valued at USD 2.5 billion in 2016. Broad product portfolio, rising awareness and efficacy in animal feed usage are the major attributed reasons for this scenario

Gut health dominated the application segment in 2016 and is expected to grow at an anticipated CAGR of 8.2% from 2017 to 2025. Eubiotics efficiency in treating gut related disorders and search for viable alternative to antibiotics are expected to drive market growth. Immunity is expected to observe the fastest growth among applications.

Fodder and water shortage, decreasing grazing lands has put pressure on livestock farmers to optimize feed utilization. Eubiotics cater to this demand by enhancing feed utilization, and increasing yield in comparatively less feed. Such trends are expected to fuel market growth over the next eight years.

Access Full Research Report on Global Eubiotics Market: http://www.grandviewresearch.com/industry-analysis/eubiotics-market

Further key findings from the report suggest:

• The global eubiotics market worth is expected to be 9.4 billion and is expected to grow at a CAGR of 8.2% from 2017 to 2025
• Solid form dominated the form segment and was valued at USD 2.9 billion in 2016. Liquid form is expected to grow at an anticipated CAGR of 8.0% over the next eight years
• The U.S. market worth for eubiotics used in poultry end use was USD 264.6 million in 2016. Rising demand for poultry meat and eggs, demand for high quality meat and concerns over antibiotics have resulted in an increased preference for usage in poultry end use.
• Asia Pacific is expected to witness the highest growth rate over the next eight years. Strong demand from countries such as China and India, growing meat consumption in the region and rising concerns over antibiotics usage is expected to fuel market growth
• Companies are focusing on developing regions such as Asia Pacific to increase market share. Key industry participants include Calpis, DSM, Novus, Lesaffre Group, Lallemand Inc., and E.I. Du Pont De Nemours and Company.

View More related Report from same category by Grand View Research: http://www.grandviewresearch.com/industry/animal-feed-and-feed-additives

Grand View Research has segmented the Global Eubiotics Market on the basis of product, form, application, end use and region:

Product Outlook (Revenue, USD Million, 2014 - 2025)

• Probiotics
• Prebiotics
• Organic Acids
• Essential Oils

Form Outlook (Revenue, USD Million, 2014 - 2025)

• Liquid Form
• Solid Form

Application Outlook (Revenue, USD Million, 2014 - 2025)

• Gut health
• Immunity
• Yield
• Others

End-use Outlook (Revenue, USD Million, 2014 - 2025)

• Cattle feed
• Dairy
• Meat
• Poultry
• Swine
• Aquatic
• Others

Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S
• Europe
• Germany
• UK
• France
• Spain
• Asia Pacific
• China
• India
• Japan
• Central & South America

• Middle East & Africa

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-eubiotics-market   

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Biochip Market Is Segmented On The Basis Of Type, End Use, Region 2013-2024

Global Biochips Anticipated Market to reach USD 25.84 billion by 2024, according to a new report by Grand View Research, Inc. Growing adoption of personalized medicine and rapid technological advancements in the biochips market along with high market demand from proteomic and genomic applications is expected to drive market growth. 

Anticipated launch and commercialization of novel products for diagnosis and treatment including laboratory- and non-laboratory-based research are expected to further reinforce growth in demand. Improvements in accuracy, resolution, and preparation procedures for the technology coupled with reduction in costs of associated materials are expected to fuel growth over the forecast period. 

Ongoing developments related to further miniaturization of biochips are expected to enhance their applicability and additional usage for genetic sequencing methodologies, such as cancer genomics. Their usage is also expected to aid reduction in the cost of genome profiling, which is a factor likely to drive demand for the next step of genetic analysis, i.e., protein expression analysis. Consequently, a growth in the number of such protein profiling studies is expected to directly fuel demand for genomic and proteomic labeling techniques through to 2024. 

Access Full Research Report on Global Biochip Market: http://www.grandviewresearch.com/industry-analysis/biochips-market

Further Key Findings From the Report Suggest:

• DNA chips form the largest revenue-generating segment of the biochip applications. Major contribution to this share comes from usage in cancer diagnostics/treatment and drug discovery applications. DNA chips accounted for around a third of the global market revenue in 2015. The other notable contributing segments to application of biochips include gene expression, single nucleotide polymorphism genotyping, genomic studies, and agricultural biotechnology.
• The market is expected to have a high potential for growth as the technology has numerous applications to aid the miniaturization of molecular biology and biochemical & chemical assays. Over time, such miniaturization is expected to benefit medical technologies in terms of cost and input requirements.
• DNA chips, lab-on-a-chip, protein chips, and tissue & cell arrays find a number of uses in pharmaceutical & biotechnology companies, academic & research institutes, hospitals & diagnostic centers, and other end users like point-of-care settings, forensic labs, blood banks, etc.
• North America was the largest revenue-generating region and accounted for over 45%of total revenue in 2015. This can be attributed to by the presence of government initiatives for personalized patient care coupled with the availability of a very large installed base of genetic and proteomic profiling platforms across the U.S. High market usage of next-gen sequencing techniques for molecular diagnosis and treatment used with microfluidic techniques also add to the large share. Furthermore, cancer analysis projects in a number of academic and clinical research institutes are also responsible for the region’s large share.
• Some key players operating in this industry include Abbott Laboratories; PerkinElmer, Inc.; GE Healthcare; Illumina, Inc.; Thermo Fisher Scientific, Inc.; Merck Millipore; Agilent Technologies, Inc.; Sigma-Aldrich Corporation; Fluidigm Corporation; and Bio-Rad Laboratories, Inc. 

View More Related Reports from same category by Grand View Research: http://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the Global Biochip market on the basis of type, end use, region:

Biochip Outlook, by Type (Revenue, USD Million, 2013 - 2024)

• DNA chips, by application
• Cancer diagnosis and treatment
• Gene expression
• Single Nucleotide Polymorphisms Genotyping
• Genomics.
• Drug discovery
• Agricultural biotechnology
•  Others
• Lab-on-a-chip, by application
• Genomics
• IVD & POC
• Proteomics
• Drug discovery
•  Others
• Protein chips, by application
• Proteomics
• Expression Profiling
• Diagnostics
• HTS
• Drug Discovery
• Others
• Tissue Arrays
• Cell Arrays

Biochip Outlook, by End Use (Revenue, USD Million, 2013 - 2024)

• Biotechnology and Pharmaceutical Companies
• Hospitals and Diagnostics Centers
• Academic & Research Institutes
• Others

Biochip Regional Outlook (Revenue, USD Million, 2013 - 2024)

• North America
• U.S.
• Canada
• Europe
• Germany
•  UK
• Asia Pacific
• China
• Japan
• Latin America
•  Brazil
• MEA
• South Africa

Access Press Release on this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-biochip-market      

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Bioactive Ingredient Market Is Segmented On The Basis Of Product, Application And Region 2014-2024

Global Bioactive Ingredient Market is expected to reach USD 51.71 billion by 2024, according to a new report by Grand View Research, Inc. Increasing disposable income coupled with growing health awareness among consumers is expected to aid the market growth. Their functional properties are capable of acting on the human metabolism physiology by providing potential health benefits.

The extraction of these bioactive compounds from original sources provides ample opportunities for adding value to food products and also improves the dietary patterns of the changed consumer’s lifestyle. They also help in preventing diseases related to heart, cancer, degenerative forms and Alzheimer’s.

Marine environment is a significant source for yielding bioactive components. Consumption of long-chain fatty acids by some fish species is strongly associated with protection from coronary heart diseases (CHD). Fish Origin Omega 3 PUFA oil are claimed to have a lot of health benefits related to a person’s diet.

Recently, it has been reported that there is an increasing demand for fish oils and fish oil fortified products across various regions. Marine organisms are potentially identified for calcium, antioxidants, anti-hypertensive proteins, selenium, and chitin. Their usage in functional food segment is regarded as the most important part and is expected to affect the overall market over the next eight years.

However, extraction of medicines derived from plants is affecting the environment by causing deforestation and is expected to affect the industry critically over the forecast period. Also, to meet the rising consumer's interest for these products, manufacturers is putting a lot of pressure on the marine organisms.

Recent technological advances such as microencapsulation are adopted for protecting bioactive ingredients from unwanted reactions and oxidation. There is a rising demand among manufacturers to find suitable solutions that provide higher productivity and adequate quality of the final products.

Access Full Research Report on Global Bioactive Ingredient Market:
http://www.grandviewresearch.com/industry-analysis/bioactive-ingredients-market

Further key findings from the report suggest:

• Fibers were the leading product segment and accounted for over 25% of global revenue in 2015. The effectiveness of fibers and rising awareness regarding its benefits are the primarily attributed reasons for this scenario.
• Functional food & beverage product segment is expected to witness the highest CAGR of 7.4% over the forecast period. The consumers owing to its potential health benefits prefer this segment.
• Asia Pacific was the leading consumer and accounted for over 35% of total revenue in 2015. The region is also expected to witness the highest growth of 7.5% over the next eight years. Changing lifestyle coupled with rising health consciousness among people particularly in China and India is drive the regional growth.
• Key industry participants include Mazza Innovation Ltd., Sabinsa Corporation, Ingredion Incorporated, BASF, Cargill Inc, Ajinomoto Co. Inc, Archer Daniel Midland Company and DuPont.

View More related reports from same category by Grand View Research: http://www.grandviewresearch.com/industry/nutraceuticals-functional-foods-and-dietary-supplements

Grand View Research has segmented the Global Bioactive Ingredient Market on the basis of product, application and region:

Global Bioactive Ingredients Product Outlook (Revenue, USD Billion, 2014 - 2024)

• Fiber
• Vitamins
• Omega 3 PUFA
• Plant extracts
• Minerals
• Carotenoids & antioxidants
• Probiotics
• Other types

Global Bioactive Ingredients Application Outlook (Revenue, USD Billion, 2014 - 2024)

• Functional food & beverages
• Dietary supplements
• Clinical Nutrition
• Personal care
• Other products

Global Bioactive Ingredients Regional Outlook (Revenue, USD Billion, 2014- 2024)

• North America
• U.S.
• Europe
• Germany
• UK
• France
• Asia Pacific
• China
• India
• Central & South America
• Middle East & Africa

Access Press Release on this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-bioactive-ingredients-market     

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Bio Polyurethane (PU) Market Is growing at an estimated CAGR of 6.5% from 2014 to 2020

Global Bio Polyurethane (PU) Market is expected to reach USD 37.5 million by 2020, according to a new study by Grand View Research, Inc. Growing preference for bio plastics on account of environmental concerns, is expected to drive global bio-PU market over the next six years. Growing demand for sustainable products from construction, automotive and footwear industries is also expected to have a positive influence on market growth. Complex manufacturing process and high cost compared to its synthetic counterpart is expected to remain a key challenge for bio-PU market participants.

Flexible foam was the largest product segment and accounted for 49% of total market volume in 2013. Increasing demand from automotive and furniture industries coupled with consumer shift towards adoption of bio-based products is expected to drive this segment. Flexible foam is also expected to witness the highest growth rate over the next six years. The segment is expected to grow at an estimated CAGR of 6.7% from 2014 to 2020.

Access Full Research Report on Global Bio Polyurethane (PU) Market Analysis:
http://www.grandviewresearch.com/industry-analysis/bio-based-polyurethane-industry

Further key findings from the study suggest:

• Global bio-PU market was 1,634.0 tons in 2013 and is expected to exceed 2,546.6 tons by 2020, growing at an estimated CAGR of 6.5% from 2014 to 2020.
• Construction was the largest end-use industry for bio-PU market and accounted for 35% of total volume in 2013. Increasing construction of green buildings coupled with growing consumer preference towards eco-friendly construction materials such as spray foams and coatings, adhesives, sealants & elastomers (CASE) is expected to drive the market.
• Automotive applications are expected to dominate bio-PU market, with demand estimated to grow at a CAGR of 7% from 2014 to 2020. Increasing flexible foam demand from major automotive OEMs, especially in the U.S., for car seats, headrests and dashboard is expected to drive the market. European Commission regulation for reducing vehicle weight in order to limit emissions is also expected to have a positive impact on the market growth.
• Asia Pacific was the largest regional market and accounted for over 30% of total volume in 2013. Availability of natural oil in abundance particularly in South East Asia coupled with government support in the form of tax benefits and financial incentives in countries such as China and India is expected to drive the regional bio-based PU market. Asia Pacific is also expected to witness the highest growth rate over the next six years, at an estimated CAGR of 8.4% from 2014 to 2020.
• Major synthetic polyurethane manufactures have shifted focus towards developing sustainable and environment friendly products. For this purpose, several market players have collaborated with biotechnology firms to synergize their expertise to manufacture bio-based polyurethane. For instance, Lubrizol acquired Merquinsa and integrated its bio TPU products to its portfolio in November 2011. Other major players operating in global bio-based PU market include BASF SE, Bayer MaterialScience, The Dow Chemical Company, Biobased Technologies and Mitsui Chemicals.

View more related reports from same category by Grand View Research: http://www.grandviewresearch.com/industry/renewable-chemicals

For the purpose of this study, Grand View Research has segmented the Global Bio-Based Polyurethane (PU) Market on the basis of product, end-use and region:

Global Bio-Based Polyurethane (PU) Product Outlook (Volume, Tons, Revenue, USD Million, 2012 - 2020)
    • Rigid Foams
    • Flexible Foams
    • CASE
    • Others
Global Bio-Based Polyurethane (PU) End-Use Outlook (Volume, Tons, Revenue, USD Million, 2012 - 2020)
    • Furniture & Interiors
    • Construction
    • Automotive
    • Footwear
    • Others
Global Bio-Based Polyurethane (PU) Regional Outlook (Volume, Tons, Revenue, USD Million, 2012 - 2020)
    • North America
    • Europe
    • Asia Pacific
    • RoW

Access Press Release on this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-bio-based-polyurethane-industry    

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Bio Vanillin Market Is Segmented On The Basis Of End Use And Region 2013-2024

Global Bio-Vanillin Market is expected to reach USD 227.7 million by 2024, according to a new report by Grand View Research, Inc. Bio vanillin is used in a broad range of applications including food & beverages, cosmetics, and pharmaceuticals on account of its superior flavor inducing properties which will result in propelling demand over the forecast period.

Increasing production through the microbial conversion process will be a major factor in realizing the full potential of bio vanillin over the forecast period. This factor will have a positive impact on the overall market. Its ability to mask the bitter taste in medicines will also play a significant role in increasing its penetration in the pharmaceutical sector.

Access Full Research Report on Global Bio Vanillin Market: http://www.grandviewresearch.com/industry-analysis/bio-vanillin-market

Further key findings from the report suggest:

• Pharmaceuticals are expected to remain a high potential segment for the product owing to its increasing application as a flavoring agent in various medicinal syrups and tablets. It is projected to experience significant volume gains at a CAGR of 8.3% over the forecast period. Moreover, its non-dispersive properties make it a viable option for use as an intermediate for synthesizing pharmaceuticals.
• Fragrances were the second largest segment and accounted for 24.2% of the global volume share in 2015. Flavors and fragrances have a broad range of applications in various industries including cosmetics, detergents, personal care products, and chemical formulations. Growing consumer awareness about natural products has also influenced the demand for natural fragrances.
• Asia Pacific was the largest market accounting for 37.9% of the global volume share in 2015. The growth of the food & beverage sector in emerging economies including China and India has been a primary growth factor for driving the demand for flavors & fragrances.
• Asia Pacific was the largest producer of natural vanillin owing to the presence of vast farmlands of the crop in Malaysia. However, high demand for vanillin which outpaces the production on account of the presence of numerous food & beverage and pharmaceutical manufacturers has resulted in manufacturers looking at alternative methods of increasing production. Growing demand for biobased products due to their environment friendly characteristics and properties equivalent to synthetic counterparts has led to an increasing commercialization and usage of bio vanillin over the past few years, and the trend is anticipated to continue over the forecast period.
• Europe is expected to witness substantial gains over the forecast period on account of high consumer demand for biobased products. Moreover, the presence of stringent regulatory framework supporting the use of biobased products, especially in food & beverages and fragrances, is expected to propel the demand for bio vanillin in the region over the forecast period.
• Major bio vanillin manufacturers include Ennloys, Solvay S.A., Apple Flavor & Fragrance Group Co Ltd, International Flavors & Fragrances, Inc. and Evolva Holding. Joint ventures and partnerships are expected to be a key feature of the market to develop advanced biotechnology.

View More related reports from same category by Grand View Research: http://www.grandviewresearch.com/industry/nutraceuticals-functional-foods-and-dietary-supplements

Grand View Research has segmented the Global Bio Vanillin Market by end use and region:

Application Outlook (Volume, Tons; Revenue, USD Million, 2013 - 2024)

• Food & beverage
• Fragrance
• Pharmaceuticals

Regional Outlook (Volume, Tons; Revenue, USD Million, 2013 - 2024)

• North America
• U.S.
• Europe
• Germany
• UK
• France
• Asia Pacific
• China
• India
• Japan
• Latin America
• Brazil
• Middle East & Africa (MEA)

Access Press Release on this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-bio-vanillin-market  

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Vertical Farming Market Quantitative Analysis By Market Size, Estimates, And Forecast From 2014 To 2025

Global Vertical Farming Market is anticipated to reach USD 9.9 billion by 2025, according to a new report by Grand View Research, Inc. The increased use of Internet of Things (IoT) sensors, for producing crops, is likely to spur the market demand over the forecast period. The information obtained from the sensors is stored on the cloud and analyzed to perform the required actions. The growing automation in agriculture and increasing use of big data & predictive analytics, for maximizing yields, are also likely to drive the market.

Genetically modified organisms and environmental & health effects of pesticides & other non-natural substances that are used for increasing agricultural production have encouraged the consumers to adopt organic foods. According to the Organic Trade Association, the U.S. organic industry sales increased by 11% in 2015, owing to the increased investment in infrastructure and education. As per the Organic Foods Production Act of 1990 the handlers and growers of organic products need to comply with the regulations

Artificial lighting helps in extending the hours of the natural daylight which further increases the health, growth rate and yield of the plants. Artificial lighting, such as high-pressure sodium lighting, LED lighting can extend the availability of crops (throughout a season). LED lighting systems produce dual-band color spectrum and generate low heat. They are anticipated to witness significant growth over the forecast period.

Hydroponic system is a method of growing plants without soil. A hydroponic system eliminates the need for pesticides and artificial ripening agents and helps in producing nutritionally-rich vegetables. However, factors, such as high initial investment and fewer crop varieties, are likely to restrain the market growth.

Access Full Research Report on Global Vertical Farming Market:
http://www.grandviewresearch.com/industry-analysis/vertical-farming-market

Further key findings from the report suggest:

• The escalating production of biopharmaceutical products is anticipated to drive the market
• The building-based segment is expected to portray high growth rate with a CAGR of 24.8% over the projected period
• The climate control segment is expected to witness high growth rate over the forecast period, as the growth of crops can be controlled by monitoring and adjusting the concentrations of minerals
• The aeroponics segment is also expected to have considerable growth over the forecast period, as the aeroponics facilitates fast growth in plants (under normal conditions)
• The North American regional market is expected to have significant growth over the forecast period, owing to the expansion of small-scale, commercial vertical farms
• The key players of the market include BrightFarms (U.S.), Everlight Electronics Co., Ltd. (Taiwan), and Green Sense Farms, LLC (U.S.)

View More Related Reports from same category by Grand View Research: http://www.grandviewresearch.com/industry/emerging-and-next-generation-technologies

Grand View Research has segmented the Global Vertical Farming Market based on structure, offering, growing mechanism, and regions:

Vertical Farming Structure Outlook (Revenue, USD Million; 2014 - 2025)

• Shipping container
• Building-based

Vertical Farming Offering Outlook (Revenue, USD Million; 2014 - 2025)

• Lighting
• Hydroponic components
• Climate control
• Sensors

Vertical Farming Growing Mechanism Outlook (Revenue, USD Million; 2014 - 2025)

• Hydroponics
• Aeroponics
• Aquaponics

Vertical Farming Regional Outlook (Revenue, USD Million; 2014 - 2025)

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Asia Pacific
• China
• India
• Japan
• South America
• Brazil
• Middle East and Africa (MEA)

Access Press Release on this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-vertical-farming-market  

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com